GPT and metabolic dysfunction-associated steatotic liver disease: Additionally, CAMEUS significantly correlated with objective measurements relevant to obesity, NAFLD, and other metabolic comorbidities, including weight (R2 = 0.374), BMI (R2 = 0.297), HbA1C (R2 = 0.126), triglycerides (R2 = 0.069), alanine aminotransferase (R2 = 0.029), all P <0.05 (Figure 4).